Health-related quality of life in injury patients: the added value of extending the EQ-5D-3L with a cognitive dimension by Ophuis, R.H. (Robbin) et al.
Vol.:(0123456789) 
Quality of Life Research (2019) 28:1941–1949 
https://doi.org/10.1007/s11136-019-02156-2
Health-related quality of life in injury patients: the added value 
of extending the EQ-5D-3L with a cognitive dimension
Robbin H. Ophuis1 · Mathieu F. Janssen2 · Gouke J. Bonsel1,3 · Martien J. Panneman4 · Suzanne Polinder1 · 
Juanita A. Haagsma1
Accepted: 27 February 2019 / Published online: 18 March 2019 
© The Author(s) 2019
Abstract
Introduction The EQ-5D is frequently used to understand the development of health-related quality of life (HRQL) following 
injury. However, the lack of a cognition dimension is generally felt as disadvantageous as many injuries involve cognitive 
effects. We aimed to assess the added value of a cognitive dimension in a cohort of injury patients.
Methods We analyzed EQ-5D-3L extended with cognition (EQ-5D + C) dimension responses of 5346 adult injury patients. 
We studied dimension dependency, assessed the additional effect of the cognitive dimension on the EQ-VAS, and, using 
the EQ-VAS as a dependent variable, determined the impact of EQ-5D and EQ-5D + C attributes in multivariate regression 
analyses.
Results Extreme cognitive problems combined with no problems on other dimensions are uncommon, whereas severe prob-
lems on other dimensions frequently occur without cognitive problems. The EQ-VAS significantly decreased when cognitive 
problems emerged. Univariate regression analyses indicated that all EQ-5D + C dimensions were significantly associated 
with the EQ-VAS. Exploratory analyses showed that using any set of five of the six EQ-5D + C dimensions resulted in almost 
identical explained variance, and adding the remaining 6th dimension resulted in a similar additional impact.
Conclusions The addition of the cognition dimension increased the explanatory power of the EQ-5D-3L. Although the 
increase in explanatory power was relatively small after the cognition dimension was added, the decrease of HRQoL (meas-
ured with the EQ-VAS) resulting from cognitive problems was comparable to the decreases resulting from other EQ-5D 
dimensions.
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Introduction
Due to improved survival rates, more individuals experi-
ence long-term consequences of injury. Assessing variations 
of health-related quality of life (HRQL) following injury is 
valuable to inform patients and to improve quality of care 
[1]. Furthermore, this information provides insight into the 
patient’s perception of recovery and his/her adaptation to the 
chronic consequences [2, 32, 3].
The EQ-5D is a widely used generic HRQL instrument 
which has been validated for both description and valua-
tion of quality of life impact [4, 5]. Its concise generic for-
mat makes it particularly useful for repeated measurements 
(minimal burden). However, the question whether dimen-
sions should be added to the EQ-5D from a generic perspec-
tive has been debated and researched since its launch in the 
beginning of the 1990s. These additional dimensions are 
referred to as bolt-on dimensions (‘bolt-ons’); dimensions 
that describe additional specific health problems. Krabbe 
et al. [6] were the first to report that the extension of EQ-5D 
with a cognitive dimension adds information. Subsequently, 
several authors suggested valuable bolt-ons, including 
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vision, energy, sleep, and skin irritation [7–9]. Two recent 
studies have used systematic approaches to identify possible 
bolt-ons for the EQ-5D from a range of items, including 
multiple items related to cognition and memory [10, 11]. 
Both these studies found that cognition is a relevant bolt-on 
for the EQ-5D, and possibly one of the most important ones 
[10, 11]. However, the relevance of the cognitive bolt-on in 
injury patients has not been investigated yet, even though 
cognitive impairments due to traumatic brain injury (TBI) 
and/or post-traumatic stress symptoms occur relatively fre-
quently in this patient population [12–14].
Our paper addresses the following questions: (a) To what 
extent are the health impacts on the dimensions related, in 
particular: does cognition represent a statistically independ-
ent dimension?; (b) Do patients with cognitive problems 
report poorer EQ-VAS scores than patients without cognitive 
problems?; (c) What is the overall explanatory power of the 
EQ-5D-3L without and with the additional cognitive dimen-
sion using the EQ-VAS score as reference?
Methods
Study population and data collection
We analyzed data of the Dutch Injury Surveillance system 
(DISS). The DISS gathers data on intentional and unin-
tentional injuries sustained by visitors to the emergency 
department (ED) of 13 hospitals throughout the Nether-
lands (12–15% coverage) [15]. The participating hospitals 
are a representative sample of hospitals in the Netherlands 
[16]. The ED visits recorded by these hospitals are generally 
considered to be representative for the total Dutch injury-
related ED visits [16]. Information that is tracked by the 
DISS includes the cause, nature, and severity of injury, age, 
and sex of the patient and health care consumption during 
hospital admission (e.g., length of stay, admission to the 
Intensive Care unit). In the DISS hospitals, the ED patients 
are informed about the DISS registry with posters and leaf-
lets that are placed in main patient areas of the ED. The post-
ers and leaflets also explain that participants can withdraw 
from the DISS registry at any time.
DISS follow-up surveys
In 2001–2002 and 2007–2008, follow-up surveys were 
sent to a stratified sample of ED patients registered in the 
DISS 2.5 months after their visit to the ED due to an injury. 
The aim of these follow-up surveys was to collect data on 
HRQL, psychological consequences, return to work, and 
health care consumption after discharge from the hospital. 
These data are additional to the data tracked by the DISS. 
The 2001–2002 follow-up survey was sent to 10,612 patients 
and the 2007–2008 follow-up to 9907 patients. Severe and 
less common injuries were intentionally overrepresented for 
follow-up. For the follow-up surveys, a written informed 
consent form was sent by mail to the selected sample of 
ED patients together with the first follow-up questionnaire 
with the request to read, sign, and return with the filled-out 
questionnaire. In this way, written informed consent forms 
were obtained from all the respondents of the questionnaire. 
The follow-up studies were approved by the Medical Ethics 
Committee of the Academic Medical Center of Amsterdam 
(AMC).
Detailed information about the DISS follow-up surveys is 
presented in the articles by Polinder et al. [15] and Haagsma 
et al. [17].
Data
EQ-5D outcome data
The EQ-5D is a generic HRQL instrument [5]. The instru-
ment for self-assessment consists of a health classification 
(the EQ-5D descriptive system), and a subjective health rat-
ing (the EQ-VAS) with a score ranging from 0 (worst imagi-
nable health state) to 100 (best imaginable health state). The 
EQ-5D descriptive system has five dimensions: mobility, 
self-care, usual activities, pain/discomfort, and anxiety/
depression with ordinal response options. The EQ-5D is 
available in two response versions: the three-level version 
(EQ-5D-3L) and the more recent five-level version (EQ-
5D-5L). The DISS follow-up surveys used the EQ-5D-3L. 
The ordinal levels of the EQ-5D-3L version are ‘no prob-
lems,’ ‘some problems,’ and ‘extreme problems/unable to.’ 
With five dimensions and three levels, the system creates 
243 potential health profiles. A profile of ‘11111’ represents 
the best possible health state, whereas the profile ‘33333’ 
represents the worst possible health state. These health 
profiles have been valued by representative samples of the 
general population [18, 19]; from their values, a value set 
has been derived allowing the calculation of a utility score 
for any health profile. We used the value set derived from 
preferences of the general population of the Netherlands to 
calculate utility scores [20].
In current DISS follow-up surveys, the EQ-5D-3L was 
extended with a three-level cognition dimension cover-
ing aspects of memory, understanding, concentration, and 
thinking [6]. The text format was similar to that of the 
other dimensions, applying identical level descriptors. The 
verbatim presentation of the descriptor for the dimension 
added to the EQ-5D was as follows “Cognitive functioning, 
such as remembering, concentrating,” with the following 
levels (1) “I have no impairment of cognitive functioning,” 
(2) “I have some impairment of cognitive functioning,” (3) 
“I have severe impairment of cognitive functioning.” The 
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EQ-5D-3L and the additional cognitive dimension (together 
labeled ‘EQ-5D + C’) were simultaneously administered. 
Only respondents with completed EQ-5D + C and EQ-VAS 
response were selected for analysis.
Supplemental DISS injury data
Apart from EQ-5D outcome data, the DISS follow-up sur-
veys included questions on general socio-demographics, 
cause, and type of the injury according to the EUROCOST 
type of injury categories, health care use, expenditures, and 
return to work [21].
Socio-demographic data
The following socio-demographic data were available: 
gender, age in years, hospital admission after ED visit, 
comorbidity, and education level. Comorbidity was present 
if a patient reported one or more of the following health 
problems: chronic obstructive pulmonary disease (COPD) 
or asthma, heart disease including a previous myocardial 
infarction, previous stroke, diabetes mellitus, hernia, (rheu-
matoid) arthritis, and cancer. We coded the completion of 
higher professional education or university education as high 
education level.
Data analysis
Dimension dependence
Two related questions are relevant if new dimensions are 
considered. (1) To what extent are the descriptive scores 
on the dimensions related (dependent)? (For example: the 
best level in mobility usually corresponds to best level in 
usual activities, or the level of self-care is never better than 
the lowest level of any of the other dimensions, a case of 
dominance or no relation beyond chance agreement.) (2) Are 
the contributions of the dimensions to the total utility score 
related? Note that two dimensions may be strongly related 
in a descriptive way, while they may still have independent 
roles in utility terms. Reversely, independent dimensions 
in a descriptive way may show strong interaction in util-
ity terms, which may be cancelation or enhancement of the 
disutility associated with either of them. A new dimension at 
least should show both additional descriptive power and an 
independent utility role, preferably also at the non-extreme 
levels. This paper focuses on descriptive independence, 
question 1, and tentatively addresses question 2 by analysis 
of EQ-VAS data (see below). The EQ-VAS was used as a 
proxy of HRQL in this analysis.
To check descriptive dependence, we created cross tables 
between pairs of dimensions, specifically checking instances 
of dominance/subordination of the cognitive dimension. The 
following procedure was developed. We considered the pro-
files with level 3 (L3; extreme problems) on one dimension 
(A) and level 1 (L1; no problems) on another dimension (B). 
Then we defined ‘dominance of dimension A across B’ as 
the presence of less combinations of A-L3 and B-L1, than 
of A-L1 and B-L3, corrected for chance frequency of these 
combinations. This definition catches ‘negative’ dominance, 
defined as the mechanism that dysfunction in dimension A 
is paralleled by dysfunction in each other dimension, limit-
ing the probability of a high level. In our context ‘positive’ 
dominance is of no interest, i.e., a high level of dimension 
A limits the presence of poor levels elsewhere. The authors 
formulated hypotheses regarding the dominance of domains 
through discussion. For the cognition domain, we hypothe-
sized that cognition dominates self-care and usual activities. 
It was deemed plausible that severe cognitive problems co-
occur with severe problems with self-care and usual activi-
ties, but not the other way around. The plausibility of the 
remaining domains combination falls outside the scope of 
this paper, and are therefore not further discussed.
In our data analysis, we first estimated the probability 
of all possible level 3 and level 1 dimension combinations 
under independence, based on multiplication of the marginal 
frequencies of the levels per dimension using the following 
formula:
where D1_L1 is dimension 1 (e.g., mobility) level 1 and 
D2_L3 is dimension 2 (e.g., self-care) level 3.
For instance, if mobility_L3 had a prevalence of 10% and 
usual activities_L1 had a prevalence of 60%, the estimated 
expected conditional probability of mobility_L3 and usual 
activities_L1 is 6%. Then we listed all prevalent EQ-5D + C 
profiles of our dataset, and selected among them the pairs 
with contrasting results (some pairs qualify for multiple con-
trasts, e.g., the profile 112,313 contains 6 L1–L3 contrasts). 
We compared the number of L1–L3 versus L1–L3 contrasts 
for dimension combinations with cognition as one of the two 
dimensions, and calculated the relative frequency of both 
contrasts, i.e., the observed frequencies relative to chance 
frequencies. E.g., cognition level 3 and pain/discomfort level 
1 versus pain/discomfort level 3 and cognition level 1. The 
ratio of the relative frequencies (cognition L1 & dimension 
× L3 as denominator) decides on dominance: if it is 1.0 
then dimensions are independent, if it is < 1.0 than cognition 
dominates, if > 1.0 then cognition is subordinate.
Dimension dependency was additionally investigated by 
calculating Spearman’s rank correlation coefficients between 
the six EQ-5D + C dimensions.
Probability (D1_L1| D2_L3)
= prevalence (D1_L1) × prevalence (D2_L3),
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Effect of cognition level on EQ-VAS
The effect of cognition level on the EQ-VAS was investi-
gated by calculating the average EQ-VAS score for each 
cognition level irrespective of the corresponding EQ-5D 
profile. The same step was repeated for EQ-5D profiles with 
relatively severe and mild problems on the other dimensions, 
which allowed for direct comparison of the EQ-VAS scores 
as only the cognition dimension levels differed within the 
complete EQ-5D + C profiles.
Explanatory power analysis of all dimensions
We then predicted the EQ-VAS score from the EQ-5D 
dimensions, the cognitive dimension, and the socio-demo-
graphic factors. Univariate and multivariate regression 
analysis was applied. All descriptive EQ-5D + C dimen-
sions were dummy coded (= standard): ‘some problems’ and 
‘severe problems’ with ‘no problems’ as reference category. 
Separate and combined analyses were performed for par-
ticipants with reported full health (EQ-5D profile of 11111) 
and without full health because of the combined effect of 
many respondents reporting to be in full health and the non-
linear relations in the upper part of the scale. Only complete 
responses of the EQ-5D, cognition question, and EQ-VAS 
were selected for analysis.
Firstly, we performed univariate regression analyses 
and predicted the EQ-VAS with the EQ-5D and cognition 
attributes. Subsequently, a multivariate regression analy-
ses model was constructed including the original EQ-5D 
attributes. In the second step, the cognition attributes were 
added to the model in order to examine the additive effect. 
Multivariate regression analysis was also used to assess the 
explanatory power of any set of combinations of five of the 
six EQ-5D + C dimensions.
Secondly, the EQ-5D attributes, cognition attributes, and 
all socio-demographic characteristics were simultaneously 
offered (forced entry) to a multivariate regression model 
explaining the EQ-VAS score. The initial model contained 
first-degree interactions. The backward deletion strategy 
was employed, starting from a model with 16 variables. 
We deleted non-significant predictors from the model until 
only significant predictors remained (p < 0.05). The regres-
sion analyses were repeated for patients with specific injury 
categories to explore the effect of the cognition dimension 
among patients with and without traumatic brain injury 
(clinical known-group comparison).
All analyses were conducted using SPSS V.24 (Statistical 
Package for Social Sciences, Chicago, Illinois, USA).
The following hypotheses were formulated:
1. There are no redundancies and dependency patterns in 
the domains of the EQ-5D-3L, but they may exist when 
cognition domain is added.
2. There is no added descriptive value of cognitive infor-
mation, i.e., the coefficient size of cognitive information 
(in cross-sectional explanatory analysis) is smaller than 
that of the least important EQ-5D3L domain, regardless 
whether socio-demographics are added.
3. The explanatory power of the EQ-5D + C is higher com-
pared to the EQ-5D in TBI patients due to specific cog-
nitive symptoms after TBI.
Results
Descriptive results
Figure 1 describes the flow chart of the participant selec-
tion, follow-up, and response. The combined response rate 
of the 2001 and 2007 follow-up surveys was 6194 (37.3%), 
of which 5346 (32.2%) had complete responses of the 
EQ-5D + C and EQ-VAS at 2.5 months follow-up. The char-
acteristics of the respondents are listed in Table 1. Respond-
ers were significantly older than non-responders (median age 
49.9 vs. median age 47.5, p < 0.01); the proportion females 
was higher (50.7% vs. 43.4%, p < 0.01); and the proportion 
of patients admitted to hospital was higher (56.1% vs. 46.9%, 
p < 0.01).
In total, 150 out of 243 (61.7%) possible EQ-5D pro-
files were reported. The responses to the dimensions of the 
EQ-5D + C indicated that the pain/discomfort dimension was 
most affected at 2.5 months follow-up (62.4% reporting any 
problems), followed by usual activities (57.6% reporting any 
problems). The cognitive dimension was the least affected 
Fig. 1  Patient flow chart
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(19.6% reporting any problems). Extreme problems (level 3) 
were most frequently reported in the usual activities dimen-
sion (15.5%), whereas extreme problems were least reported 
in the mobility and cognition dimensions (both 2.7%). A 
total of 1419 respondents (26.5%) reported no problems on 
any dimension and thus had an EQ-5D profile of 11111. 
Respondents with a 11111 profile were more likely to be 
male (61.8% vs. 44.8%; p < 0.01) and younger (mean age 
41.8 years vs. 52.9 years; p < 0.01), less likely to be admit-
ted to the hospital (30.9% vs. 65.2%, p < 0.01) and had fewer 
comorbidities (16.8% vs. 43.8%, p < 0.01).
Dimension dependency
Figure 2 describes our expectations regarding the likeli-
hood of possible contrasting dimensions. We distinguished 
likely, unlikely, and very unlikely contrasting dimen-
sion levels which were based on agreement between the 
authors. We defined ‘unlikely’ as unlikely, but possible in 
certain cases. Our results showed that all unlikely com-
binations did occur (0.04–1.31% of all observed combi-
nations). Especially, the cognition level 1 and pain/dis-
comfort level 3 was observed relatively frequent (n = 132, 
2.3% of total observed EQ-5D + C profiles) (Fig. 2). We 
found that level 3 cognition in combination with level 1 
combinations on all other dimensions were uncommon 
(< 1%), especially with usual activities. On the contrary, 
level 1 cognition and level 3 of other dimension com-
binations occurred more frequently (> 1%), especially 
usual activities level 3 (9.0%). The ratio of the relative 
frequencies of cognition L3 & dimension L1 and cogni-
tion L1 & dimension L3 was < 1.0 for all the dimensions. 
These findings indicate that cognition is dominant over 
the other dimensions: extreme cognitive problems and no 
problems on other dimensions are uncommon, whereas 
extreme problems on other dimensions frequently occur 
with no cognitive problems. The Spearman’s rank correla-
tion coefficients between the six dimensions ranged from 
0.592 (usual activities and pain/other) to 0.223 (mobility 
Table 1  Characteristics of the respondents (aged 15 and older)
SD standard deviation, IQR interquartile range
a Median length of stay of patients who were admitted to hospital after 
their ED visit
Respondent demographics
n 5346
Age (mean) 49.9 (SD 21.5)
Females 50.7%
Type of injury
 Skull-brain injury 11.8%
 Facial fracture, eye injury 3.9%
 Spine, vertebrae 5.0%
 Internal organ injury 6.1%
 Upper extremity fracture 12.9%
 Upper extremity, other 6.4%
 Hip fracture 6.8%
 Lower extremity fracture 16.1%
 Lower extremity, other 9.9%
 Superficial injury, open wounds 16.4%
 Burns 0.8%
 Poisonings 0.8%
 Other injury 3.3%
 Hospitalization 56.1%
 Length of  staya (median, IQR) 4.0 [2.0–11.0]
Fig. 2  EQ-5D + C level 1 and 
3 combinations, in absolute 
numbers and expressed as the 
percentage of total EQ-5D + C 
profiles (n = 5346)
MO_L1 SC_L1 UA_L1 PD_L1 AD_L1 CO_L1
MO_L3 X 12 (0.22%) 2 (0.04%) 8 (0.15%) 30 (0.56%) 58 (1.08%)
SC_L3 23 (0.43%) X 5 (0.09%) 24 (0.45%) 81 (1.52%) 94 (1.76%)
UA_L3 134 (2.51%) 233 (4.36%) X 72 (1.35%) 378 (7.07%) 479 (8.96%)
PD_L3 48 (0.90%) 68 (1.27%) 5 (0.09%) X 70 (1.31%) 123 (2.30%)
AD_L3 43 (0.80%) 65 (1.22%) 17 (0.32%) 16 (0.30%) X 55 (1.03%)
CO_L3 26 (0.49%) 30 (0.56%) 4 (0.07%) 20 (0.37%) 29 (0.54%) X
MO: mobility, SC: self-care, UA: usual acvies, PD: pain/discomfort, AD: anxiety/depression, CO: 
cognion. 
Expected likelihood of combinaons
Light grey: likely
Darker grey: unlikely
Darkest grey: very unlikely
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and cognition). The Spearman’s correlation coefficients 
between cognition and each of the EQ-5D dimensions was 
lower than 0.31, except for the dimension anxiety/depres-
sion (Spearman’s correlation coefficient = 0.42). For the 
other dimensions, only the Spearman’s correlation coef-
ficient for mobility and anxiety/depression was lower than 
0.31 (Spearman’s correlation coefficient = 0.30).
EQ-VAS by cognition level for various profiles
The average EQ-VAS for each cognition level, combining 
all profiles given a particular cognition level, is described in 
Table 2. The EQ-VAS significantly decreased when cogni-
tive problems increased [no problems mean EQ-VAS 74.5 
(95% confidence interval (CI) 74.0–75.0)]; moderate prob-
lems EQ-VAS 57.7 (95% CI 56.5–59.0); extreme problems 
mean EQ-VAS 41.1 (95% CI 37.7–44.4), which showed that 
cognitive problems are associated with a decrease of the EQ-
VAS. The analyses for specific profiles (Table 2) show the 
same trend, although the decrease of the EQ-VAS was not 
significant for all profiles, probably due to low sample sizes.
Univariate regression analysis
Univariate regression analyses indicated that all EQ-5D + C 
dimensions were significantly associated with the EQ-VAS 
(Table 3). The direction of the relative size of level 2 and 
level 3 impairments of the same dimension was as expected, 
with extreme problems on any dimension resulting in greater 
deficits of the EQ-VAS compared to moderate problems. 
In univariate analysis, extreme problems with performing 
usual activities explained most of the variance of the EQ-
VAS (17.3%). Moderate and extreme cognitive problems 
explained, respectively, 8.7% and 6.2% of the variance of the 
EQ-VAS. For the non-11111 profiles, moderate and extreme 
cognitive problems explained both 6.1% of the variance of 
the EQ-VAS.
For profile 11111 respondents cognition level 2 explained, 
respectively, 0.8% of the variance of the EQ-VAS. For 
Table 2  EQ-VAS score by 
cognition level for overall 
EQ-5D profiles and for 
exemplary EQ-5D profiles with 
the most frequently reported 
level 3 cognition
95% CI 95% confidence interval
EQ-5D profile Cognition level
1 2 3
n Mean (95% CI) n Mean (95% CI) n Mean (95% CI)
All 4298 74.5 (74.0–75.0) 949 57.7 (56.5–59.0) 157 41.1 (37.7–44.4)
11111 1365 85.7 (85.1–85.4) 52 79.9 (76.6–83.2) 2 52.2 (47.6–57.4)
21221 444 70.5 (69.2–71.9) 51 61.6 (57.1–66.0) 2 47.5 (23.0–72.0)
22221 176 63.2 (60.8–65.6) 37 61.2 (56.6–65.8) 2 40.0 (20.4–59.6)
23322 13 46.9 (38.4–55.4) 17 45.7 (39.3–52.2) 15 39.1 (31.4–46.8)
33322 7 40.0 (25.7–54.3) 16 39.2 (33.6–44.8) 9 32.2 (24.5–39.9)
33333 3 18.3 (15.1–21.6) 6 17.5 (1.5–33.5) 10 14.0 (6.3–21.7)
Table 3  Association between the EQ-VAS and the EQ-5D and cogni-
tion dimensions (univariate analyses)
95% CI 95% confidence interval
EQ-5D dimension R2 Unstandardized b (95% 
CI)
p value
Mobility level 2 0.128 − 14.5 (− 15.5 to − 13.5) < 0.001
Mobility level 3 0.082 − 35.1 (− 38.3 to − 32.0) < 0.001
Self-care level 2 0.104 − 16.0 (− 17.2 to − 14.7) < 0.001
Self-care level 3 0.110 − 30.1 (− 32.3 to − 27.8) < 0.001
Usual activities level 2 0.035 − 7.5 (− 8.6 to − 6.5) < 0.001
Usual activities level 3 0.173 − 22.9 (− 24.2 to − 21.5) < 0.001
Pain/discomfort level 2 0.079 − 11.3 (− 12.3 to − 10.3) < 0.001
Pain/discomfort level 3 0.104 − 30.3 (− 32.7 to − 27.9) < 0.001
Anxiety/depression 
level 2
0.126 − 17.1 (− 18.3 to − 15.8) < 0.001
Anxiety/depression 
level 3
0.076 − 30.0 (− 32.8 to − 27.2) < 0.001
Cognition level 2 0.087 − 15.7 (− 17.1 to − 14.3) < 0.001
Cognition level 3 0.062 − 30.5 (− 33.7 to − 27.3) < 0.001
Table 4  Explanatory power of multivariate models that included any 
set of the EQ-5D and cognition dimensions (multivariate analyses)
MO mobility, SC self-care, UA usual activities, PO pain/other, AD 
anxiety/depression, CO cognition
Selection of EQ-5D + C dimensions R2 F value p value
MO + SC + UA + PD + AD 0.456 448.1 < 0.01
MO + SC + UA + PD + AD + CO 0.469 393.2 < 0.01
MO + UA + PD + AD + CO 0.459 453.3 < 0.01
MO + SC + PD + AD + CO 0.456 447.3 < 0.01
MO + SC + UA + AD + CO 0.448 433.1 < 0.01
MO + SC + UA + PD + CO 0.445 427.4 < 0.01
SC + UA + PD + AD + CO 0.454 443.7 < 0.01
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cognition level 3, this could not be calculated, since there 
were only two respondents that reported a 11111 profile and 
extreme cognitive problems.
Multivariate regression analysis
The additional cognitive dimension increased the explana-
tory power of the multivariate model from 45.6% (EQ-
5D) to 46.9% (EQ-5D + C). Exploratory analyses showed 
that using any set of five of the six EQ-5D + C dimensions 
resulted in almost identical explained variance, and adding 
the remaining 6th dimension resulted in a similar additional 
impact (Table 4).
The final model, which explained 48.7% of the variance 
of the EQ-VAS, included the EQ-5D and cognition attributes 
and comorbidity. According to the model, having comorbid 
disease is associated with a significant decrease of the EQ-
VAS (Table 5).
Traumatic brain injury versus other injury
For patients with traumatic brain injury, the additional cog-
nition dimension increased the explanatory power of the 
multivariate model from 55.6% (EQ-5D) to 56.5% (EQ-
5D + C). For non-TBI patients, this increase was slightly 
larger, namely, from 44.5% (EQ-5D) to 45.8% (EQ-5D + C).
Discussion
Our results showed that extreme cognitive problems and 
no problems on other dimensions are uncommon, whereas 
extreme problems on other dimensions frequently occur with 
no cognitive problems. Moreover, we found that the decrease 
of HRQL measured with the EQ-VAS resulting from cogni-
tive problems was significant. These findings indicate that 
cognition is dominant over the other dimensions. The addi-
tional cognitive dimension increased the explanatory power 
of the multivariate EQ-5D-3L attributes model from 45.6% 
(EQ-5D) to 46.9% (EQ-5D + C). This increase is small but 
similar to adding one of the original EQ-5D dimensions to 
any set of five EQ-5D + C dimensions.
The performance of the cognition bolt-on has been inves-
tigated in previous studies. Krabbe et al. [6] compared valu-
ations (by means of the EQ-VAS) elicited from EQ-5D + C 
descriptions with parallel EQ-5D descriptions in members 
of Dutch university staff members. The content validity 
of the EQ-5D improved by adding cognition. The authors 
emphasized the importance of considering the inclusion of a 
cognitive dimension. The employed methods were too crude 
to quantify the increased explanatory power, however. Wolfs 
et al. [22] investigated the construct validity and responsive-
ness of the EQ-5D + C and the EQ-5D in older adults with 
cognitive impairments using the Mini Mental State Exami-
nation (MMSE) as reference. Regarding construct validity, 
similar correlations between the EQ-5D and the MMSE and 
between the EQ-5D + C and the MMSE were found, which 
indicated that there were no differences in construct valid-
ity. The EQ-5D and the EQ-5D + C were both responsive to 
changes in the MMSE, but the EQ-5D performed slightly 
better. The study of Wolfs et al. [22] is difficult to compare to 
the results of our study, as the MMSE was used as reference 
and the increased explanatory power was not investigated.
There does not seem to be consensus as to what increase 
in R-square is actually meaningful [7]. For example, Swin-
burn et al. [23] reported that the addition of skin irritation 
and self-confidence dimensions to the EQ-5D-3L increased 
the R-square with 22% for psoriasis patients and concluded 
that the addition of dimensions was much better at predict-
ing outcomes. Whynes [24] reported that the addition of 
five dimensions increased the explanatory power up to 56%, 
which was defined a substantial improvement. However, 
Yang et al. [9] reported that an increase in explanatory power 
(TTO outcome) of 6% as a result of adding a sleep dimen-
sion was not a significant improvement. Compared to these 
results, an increase in explanatory power of 1.3% is rela-
tively low. However, it is comparable to increase in explan-
atory power by other EQ-5D dimensions. Moreover, the 
explanatory power of the multivariate model that included 
all EQ-5D dimensions was 45.6%. This is in the same order 
Table 5  Explanatory power of the multivariate model that included 
the EQ-5D + C dimensions and comorbidity
EQ-5D dimension Unstandardized b p value
< 0.01
Constant 87.4 < 0.01
Comorbidity − 4.0 < 0.01
Mobility level 2 − 4.8 < 0.01
Mobility level 3 − 16.4 < 0.01
Self-care level 2 − 4.2 < 0.01
Self-care level 3 − 7.2 < 0.01
Usual activities level 2 − 5.6 < 0.01
Usual activities level 3 − 10.1 < 0.01
Pain/discomfort level 2 − 5.3 < 0.01
Pain/discomfort level 3 − 16.1 < 0.01
Anxiety/depression level 2 − 7.4 < 0.01
Anxiety/depression level 3 − 11.6 < 0.01
Cognition level 2 − 6.3 < 0.01
Cognition level 3 − 10.9 < 0.01
F value 192.6
Corresponding p value p < 0.01
R2 0.487
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of magnitude as the explanatory power of a multivariate 
regression model that included the EQ-5D-3L dimensions in 
community samples [7, 25]. This indicates that variation in 
HRQL as measured with the EQ-VAS is affected by aspects 
that are not covered by the current EQ-5D items. This is 
underlined by the variation in EQ-VAS scores of respondents 
with a 11111 profile.
Strengths and limitations
The most important strength of our study is the large number 
of participants, which allowed for analyses of subgroups, 
including the additional effect of the cognition bolt-on for 
specific injury types, without losing statistical power. Fur-
thermore, EQ-5D + C responses were consistent, meaning 
that extreme problems on any dimension resulted in greater 
deficits of the EQ-VAS compared to some problems. A limi-
tation of our study is that the follow-up survey was adminis-
tered 2.5 months post-injury. Many injured patients recover 
sooner than 2.5 months [15], especially patients with minor 
injuries such as open wounds, superficial injuries, and contu-
sions. This applies also to mild traumatic brain injury such 
as concussions in particular, as it is known that cognitive 
problems are most present within 2 weeks post-injury [26]. 
Second, a limitation of our study was that the respondents 
were not a representative sample of the patients who are 
registered in DISS. Firstly, severe and less common injuries 
were intentionally overrepresented for follow-up. Secondly, 
young males were less likely to respond to our survey. As a 
result, the respondents were on average older and the per-
centage of females was higher compared to the patients that 
were registered in the DISS.
A third limitation of this study is that the EQ-VAS was 
used as a proxy of HRQL. A well-known problem of the 
EQ-VAS is that it is subject end of scale bias, a measure-
ment bias that causes respondents to avoid the extremes of 
the scale.
In this study, we administered the cognitive dimension 
question immediately after the original EQ-5D and before 
the EQ-VAS question on the same page. We assumed that 
participants answered the original EQ-5D questions in the 
same way regardless of whether the cognition question was 
included. However, the responses to the original EQ-5D 
questions may have been influenced by the added cognition 
questions and the sequence of questions.
Recommendations for future research
For future research, we recommend to investigate the added 
value of the cognitive bolt-on in a sample of trauma patients 
shortly after sustaining their injury, e.g., maximally 2 weeks 
post-injury to ensure that patients are still experiencing 
symptoms. We also recommend investigating the added 
value of the cognitive dimension in other patient groups, 
such as patients suffering from permanent traumatic brain 
injury, but also in patients groups that have illnesses that 
are not related to cognitive impairments. We furthermore 
recommend to investigate the effects of adding a cogni-
tive dimension to the EQ-5D-5L. The EQ-5D-5L improved 
the measurement properties and discriminatory power in 
comparison with the EQ-5D-3L among different patient 
groups [27]. Therefore, it is possible that a cognition bolt-on 
explains more variance of the EQ-VAS when the EQ-5D-5L 
is used.
Conclusion
The addition of the cognitive dimension increased the 
explanatory power of the EQ-5D-3L. Although the increase 
in explanatory power was relatively small after the cogni-
tion dimension was added, the decrease of HRQL (measured 
with the EQ-VAS) resulting from cognitive problems was 
comparable to the decreases resulting from other EQ-5D 
dimensions.
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